McKinney Regulatory Science Advisors, LLC, a leading regulatory science consulting firm specializing in regulatory affairs, is thrilled to announce the appointment of Dr. Ian Fearon as its new Chief Scientific Officer. With his wealth of knowledge and experience in the scientific and regulatory domains of tobacco and nicotine products, Ian will play a pivotal role in enhancing the company’s capabilities and expanding its range of services to clients.

Ian Fearon brings over 15 years of invaluable experience in the field of Tobacco Harm Reduction, with a specific focus on clinical and behavioral studies of these products. His deep understanding of regulatory submissions in the United States and Europe will enable McKinney Regulatory Science Advisors, LLC to provide unparalleled support and guidance to clients navigating the complex regulatory landscape.

Prior to joining McKinney Regulatory Science Advisors, LLC, Ian Fearon held key leadership positions at renowned organizations in the industry. As the Senior Director of Clinical and Regulatory Affairs EMEA at JUUL Labs, he played a vital role in advancing the scientific understanding of tobacco and nicotine products and supporting the JUUL PMTA submission. Ian also served as the Director of Tobacco Research at Celerion, where he contributed significantly to the development of clinical evidence to support regulatory filings. Furthermore, his tenure as Principal Scientist and Head of Clinical Research at British American Tobacco solidified his reputation as a thought leader in this space. Ian is also a prolific contributor to the scientific community and has published more than 60 papers, including more than 20 on tobacco/nicotine product assessment, which have generated more than 3,200 citations.

Commenting on the addition of Ian Fearon to the team, McKinney Regulatory Science Advisors, LLC CEO, Willie McKinney, said,

“We are thrilled to welcome Ian as our Chief Scientific Officer. His extensive experience and deep knowledge of tobacco and nicotine science & worldwide regulations make him an invaluable asset to our team. With Ian’s guidance, we will continue to provide exceptional scientific and regulatory consulting services to our clients, facilitating their success in bringing innovative consumer products to market.”

As the Chief Scientific Officer at McKinney Regulatory Science Advisors, LLC, Ian will oversee the company’s scientific operations, lead strategic initiatives, and drive innovation in the regulatory science domain. His comprehensive expertise will empower the firm to deliver tailored solutions that address the evolving needs and challenges faced by clients across the industry.

About McKinney Regulatory Science Advisors, LLC:

McKinney Regulatory Science Advisors, LLC is a leading scientific consulting firm specializing in regulatory affairs. With a team of industry experts and a deep understanding of the scientific and regulatory landscape, the company provides strategic guidance and support to clients in various sectors, including tobacco and nicotine products, cannabis consumer, and medicinal goods. McKinney Regulatory Science Advisors, LLC is committed to helping clients navigate the complex regulatory environment and achieve their business objectives while prioritizing safety and compliance.

For media inquiries, please contact:

Kim Hesse

Vice President, Sales and Marketing